- Home
- SCD vs VNDA Comparison
SCD vs VNDA Comparison
Compare SCD & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCD
- VNDA
- Stock Information
- Founded
- SCD 2003
- VNDA 2002
- Country
- SCD United States
- VNDA United States
- Employees
- SCD N/A
- VNDA N/A
- Industry
- SCD Trusts Except Educational Religious and Charitable
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- SCD Finance
- VNDA Health Care
- Exchange
- SCD Nasdaq
- VNDA Nasdaq
- Market Cap
- SCD N/A
- VNDA 270.0M
- IPO Year
- SCD N/A
- VNDA 2006
- Fundamental
- Price
- SCD $17.22
- VNDA $4.92
- Analyst Decision
- SCD
- VNDA Strong Buy
- Analyst Count
- SCD 0
- VNDA 2
- Target Price
- SCD N/A
- VNDA $15.50
- AVG Volume (30 Days)
- SCD 62.6K
- VNDA 687.2K
- Earning Date
- SCD 01-01-0001
- VNDA 02-05-2025
- Dividend Yield
- SCD 9.63%
- VNDA N/A
- EPS Growth
- SCD N/A
- VNDA N/A
- EPS
- SCD N/A
- VNDA N/A
- Revenue
- SCD N/A
- VNDA $190,858,000.00
- Revenue This Year
- SCD N/A
- VNDA $5.60
- Revenue Next Year
- SCD N/A
- VNDA $42.85
- P/E Ratio
- SCD N/A
- VNDA N/A
- Revenue Growth
- SCD N/A
- VNDA N/A
- 52 Week Low
- SCD $11.33
- VNDA $3.46
- 52 Week High
- SCD $15.87
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- SCD 56.96
- VNDA 53.06
- Support Level
- SCD $16.40
- VNDA $4.71
- Resistance Level
- SCD $17.39
- VNDA $4.90
- Average True Range (ATR)
- SCD 0.40
- VNDA 0.16
- MACD
- SCD 0.03
- VNDA 0.02
- Stochastic Oscillator
- SCD 78.81
- VNDA 86.21
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.